Tysabri News: Be Aware of its Risks
After reading a Wall Street Journal article this morning, I learned that Tysabri proves still potentially problematic for its users. Two MS patients who were using the treatment have contracted PML, or progressive multifocal leukoencephalopathy, and one has been hospitalized. Both patients are members of the European Union, according... Read more


















